Anteris Technologies Global AVR
NASDAQ AVR
$7.61 -0.16 (-2.06%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anteris Technologies Global (AVR) Return on Equity [ROE] (2024 - 2026)

Updated

Anteris Technologies Global's Return on Equity [ROE] was -38.83% in Q2 2026, up 211.34 percentage points from -250.17% a year earlier and up 29.62 percentage points from the prior quarter.

Analysis

Anteris Technologies Global (AVR) Return on Equity [ROE] (2024 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Anteris Technologies Global came in at -301.86%.

  • Per Business Quant data, AVR's Return on Equity [ROE] in the three quarters before Q2 2026 was -68.44% (Q1 2026), -5470.25% (Q4 2025) and -608.75% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 13.36%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 10.39%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 7.56%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 17.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 10.44%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -3.90%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 14.31%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 9.53%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 3.88%
10 Anteris Technologies Global 756.88 Mn 757.17 Mn 776,000.00 -38.83%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -38.83%
Mar 31, 2026 -68.44%
Dec 31, 2025 -5,470.25%
Sep 30, 2025 -608.75%
Jun 30, 2025 -250.17%
Mar 31, 2025 -154.53%
Dec 31, 2024 -231.68%
API Access

Anteris Technologies Global Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVR&period=max&api_key=YOUR_API_KEY